ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 202 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $11,000 | 0.0% | 425 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $11,000 | +57.1% | 425 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $7,000 | -22.2% | 425 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | +50.0% | 425 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | -88.9% | 425 | -82.5% | 0.00% | -87.5% |
| Q1 2018 | $54,000 | +25.6% | 2,425 | +70.2% | 0.01% | +33.3% |
| Q4 2017 | $43,000 | +168.8% | 1,425 | +235.3% | 0.01% | +200.0% |
| Q3 2017 | $16,000 | +33.3% | 425 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $12,000 | -20.0% | 425 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $15,000 | +25.0% | 425 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $12,000 | -14.3% | 425 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $14,000 | 0.0% | 425 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $14,000 | +16.7% | 425 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $12,000 | +300.0% | 425 | +325.0% | 0.00% | +100.0% |
| Q4 2014 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q3 2014 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |